Ultravac BVD provides farmers with the ability to protect their herds against the multiple strains of BVD (Bovine Viral Diarrhoea) found in New Zealand.
Ultravac BVD ensures a high level of protection against BVD transfer from mother to foetus which is a critical pathway for the disease that makes it particularly difficult to control.
Zoetis market development manager Dr Wayne Clough says increasing numbers of farmers are becoming aware of the impact BVD can have in financial and animal health terms.
“There has been a decade of research done now evaluating the impact of BVD.
“There have also been major advances in how we can detect it in herds.
“When it comes to protecting a herd from BVD, Ultravac BVD has a number of features that make it particularly useful.”
The four-week to six-month window available to deliver Ultravac BVD’s second booster shot makes it a flexible vaccine to administer, easily fitting into stock treatment programmes for dairy and drystock farmers.
Its ability to be injected under the skin, rather than into the muscle, makes it cow-friendly and easier to administer.
The 30-day in-use shelf life is significantly greater than competing vaccines, minimising wastage.
Clough says Zoetis will work closely with veterinarians to help them increase farmers’ understanding of BVD and how it can affect their farming business.
That would build on the work done by the BVD steering committee that outlined control measures every farm needs to try to reduce the incidence of BVD infection and transmission.
Ultravac BVD is now available from veterinarians nationwide.
For more information visit www.zoetis.co.nz.
